Brexpiprazole Impurity 33 CAS 98327-87-8

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.98327-87-8
Molecular FormulaC44H32P2
Molecular Weight622.67 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Brexpiprazole Impurity 33 CAS 98327-87-8 chemical structure

Description

The occurrence of Brexpiprazole Impurity 33 is closely related to organophosphorus functionality, a polycyclic aromatic system in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.

As a process- or degradation-related impurity, Brexpiprazole Impurity 33 (CAS 98327-87-8, C44H32P2) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.

Owing to organophosphorus functionality, a polycyclic aromatic system, Brexpiprazole Impurity 33 is typically pale yellow to yellow amorphous powder. Its solid-state physicochemical attributes — including a molecular weight of 622.67 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

As a certified reference material (CRM), Brexpiprazole Impurity 33 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

Physical & Chemical Properties

Molecular FormulaC44H32P2
Molecular Weight622.67 g/mol
Purity97%+
StorageStore at room temperature, protect from light
Solubility (reference)Soluble in chloroform, dichloromethane, ethyl acetate
StabilityLight-sensitive; avoid direct strong light
Degree of Unsaturation (DBE)29.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1985

Related Brexpiprazole Standards

Recommended Standards

Why CATO?